Measurement of BRAFV600E in Peripheral Blood - Is There a Gold Standard?

BRAFV600E monitoring in blood is increasingly used for establishing histiocytosis diagnosis or evaluation of responses to therapy. In this webinar, analytic details and methods for validation of commercial or inhouse developed PCR platforms will be presented and discussed. Presentations Include: BRAFV600E Monitoring from Research to the Clinic: Experience from the UK by Dr. Paul Milne Digital PCR monitoring of BRAF V600E mutational load in LCH: Experience from Japan by Dr. Ko Kudo BRAF mutation testing by allele-specific PCR: the Texas Children’s experience by Dr. Kevin Fisher Towards routine clinical implementation of duplex BRAFV600E/WT droplet digital PCR: the Dutch experience by Dr. Astrid van Halteren